Heartai Medical (02291.HK) shares are being reduced by the controlling shareholder LePu Medical, with 11.14 million H shares being sold.

Zhtng Cijng APP News, Heart-Tai Medical (02291.HK) announced that the Board of Directors of the Company has been informed by one of the Company's controlling shareholders, Leap Medical (Beijing) Medical Devices Co., Ltd. (Leap Medical, whose shares are listed on the Shenzhen Stock Exchange GEM board, stock code: 300003), that Leap Medical sold a total of 11.14 million shares of the Company's H shares in a block trade on August 26, 2025, at a price of HK$22.79 per share, representing approximately 3.21% of the total number of issued shares of the Company as of the date of this announcement. Following the sale, Leap Medical will continue to hold 268.86 million shares, including 266.06 million shares held directly by Leap Medical and 2.8 million shares held by Leap Medical's subsidiary Beijing Tiandi HeXie Technology Co., Ltd., accounting for approximately 77.54% of the Company's issued share capital as of the date of this announcement, demonstrating its strong confidence in the Company. Leap Medical is confident in the Group's business operations and the sale is aimed at improving the liquidity of the Company's stock.